On Tuesday, Shares of Pfizer Inc. (NYSE:PFE), lost -0.28% to $35.14.
Pfizer’s Centers for Therapeutic Innovation (CTI) and the Jeffrey Modell Foundation (JMF) declared a partnership agreement to conduct research in the field of immunological diseases. CTI and JMF will identify and co-fund translational research projects with leading academic medical centers within the CTI network. The aim of each research project will be to identify and validate a potential drug candidate for an immunological disease that can be moved into further clinical testing.
The partnership with CTI represents JMF’s first alliance with a biopharmaceutical company. “We are excited about the opportunity to collaborate with Pfizer as we broaden our commitment to make a world of difference in the lives of patients with immunological diseases,” said Vicki Modell, co-founder of the Jeffrey Modell Foundation. “JMF’s expertise in Primary Immunodeficiency and extensive network of collaborators, combined with Pfizer’s impressive research and development capabilities has the potential to identify and advance novel research projects. Together, we hope to make meaningful advancements in our understanding of immunological diseases.”
Pfizer Inc., a biopharmaceutical company, discovers, develops, manufactures, and sells healthcare products worldwide. The company operates through Global Innovative Pharmaceutical (GIP); Global Vaccines, Oncology and Consumer Healthcare (VOC); and Global Established Pharmaceutical (GEP) segments.
Shares of Banco Santander, S.A. (NYSE:SAN), declined -0.28% to $7.25, during its last trading session.
Santander Holdings USA, parent company of Santander Bank, N.A., declared that its Board of Directors declared a dividend on SHUSA’s Preferred Stock. A dividend payment of $0.45625 per depositary share is payable on August 17, 2015 to holders of record on August 1, 2015 for SHUSA’s Series C Non-Cumulative Perpetual Preferred Stock (NYSE:SOVPRC).
Banco Santander, S.A. provides various banking products and services for individuals and companies. The company offers various deposit products, such as demand and time deposits; mortgages, auto finance, and personal credits; consumer finance; and mobile banking and electronic banking services.
Finally, Flotek Industries Inc. (NYSE:FTK), ended its last trade with 6.37% surge, and closed at $13.03.
Flotek Industries, declared the Company’s plan for its second quarter earnings release and conference call.
Flotek will host a conference call on Thursday, July 23, 2015 at 7:00 a.m. Central Standard Time to talk about its financial and operating results for the three -months ended June 30, 2015. Flotek intends to provide dial-in information through a press release on July 22, 2015.
In addition to the Company’s traditional earnings report, Flotek will also update investors on noteworthy progress in the establishment of alternative distribution channels for its core Complex nano-Fluid® completion chemistries, the success of FracMax™ in marketing CnF® during the quarter, progress in international markets and adjustments to its Drilling Technologies business.
Flotek Industries, Inc. develops and supplies oilfield products, services, and equipment to the oil, gas, and mining industries in the United States and internationally.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties, which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified with such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should/might occur.
